Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GC CELL CORPORATION Logo
Cell and gene therapy specialist with integrated CDMO, bio-logistics, and cell banking.
South Korea
144510
Gelteq Ltd Logo
Develops and manufactures a gel-based oral delivery system for drugs and nutrients.
United States of America
GELS
GemVax & KAEL Co.,Ltd. Logo
Clinical-stage biopharma developing therapeutics for neurodegenerative diseases.
South Korea
082270
Gencurix Inc. Logo
Develops and commercializes diagnostic solutions for precision medicine in oncology.
South Korea
229000
GENEDRIVE PLC Logo
Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.
United Kingdom
GDR
GENELUX Corp Logo
Clinical-stage biopharma developing oncolytic viral immunotherapies for solid tumors.
United States of America
GNLX
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostic products for infectious diseases.
South Korea
109820
Generation Bio Co. Logo
Develops siRNA therapeutics delivered via ctLNPs for T cell-driven autoimmune diseases.
United States of America
GBIO
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
South Korea
095700
Genfit S.A. Logo
Biopharmaceutical firm developing therapies and diagnostics for liver diseases.
United States of America
GNFT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.